Joohyuk Sohn

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Joohyuk Sohn

Apr 9, 2025, 08:51 | Drugs

Elvina Almuradova: Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

Elvina Almuradova, Ambassador at European School of Oncology, shared an article Komal Jhaveri and her…

Feb 27, 2025, 11:45 | Blog

Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: "Here’s the most recent Breast Cancer…

Dec 12, 2024, 16:50 | Insight

Imlunestrant and Abemaciclib: A Study in Advanced Breast Cancer

Imlunestrant has been approved for the treatment of breast cancer. It is a next-generation, brain-penetrant,…

Dec 12, 2024, 13:36 | Blog

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

Erika Hamilton, The Director of Breast Cancer Program at Sarah Cannon Research Institute, shared on…

Oct 4, 2024, 15:09 | Blog

Phase 3 EVER-002 trial is out

Paolo Tarantino shared an article by Binghe Xu on X: "Phase 3 EVER-002 trial (also…

Sep 19, 2024, 09:29 | Insight

Guilherme Nader Marta: DESTINY-Breast06 trial out in The New England Journal of Medicine

Guilherme Nader Marta, Advanced Clinical Fellow - Dana-Farber Cancer Institute, shared a post on LinkedIn: "DESTINY-Breast06…

Jun 5, 2024, 15:22 | Insight

Piotr Wysocki: T-DXd in metastatic ER+/HER2-low breast cancer patients after endocrine treatment failure

Piotr Wysocki recently posted on LinkedIn: "Results of a Destiny-Breast06 trial have been presented by…

All: 7 Posts: 1 - 100

'

April is Head and Neck Cancer Awareness Month

'

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

'

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

'

Cancer Center Near Me: Dana-Farber Cancer Institute

'

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023